Clone Phylogenetics Reveals Metastatic Tumor Migrations, Maps, and Models

被引:5
|
作者
Chroni, Antonia [1 ,2 ]
Miura, Sayaka [1 ,2 ]
Hamilton, Lauren [1 ,2 ]
Vu, Tracy [1 ,2 ]
Gaffney, Stephen G. [3 ]
Aly, Vivian [1 ,2 ]
Karim, Sajjad [4 ]
Sanderford, Maxwell [1 ,2 ]
Townsend, Jeffrey P. [3 ,5 ,6 ]
Kumar, Sudhir [1 ,2 ,4 ]
机构
[1] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA
[2] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA
[3] Yale Univ, Dept Biostat, New Haven, CT 06510 USA
[4] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 22252, Saudi Arabia
[5] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06525 USA
[6] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06511 USA
基金
美国国家卫生研究院;
关键词
tumor evolution; metastasis; molecular evolution; phylogenetics; phylodynamics; cancer; HETEROGENEITY;
D O I
10.3390/cancers14174326
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Metastasis is the spread of cancer cells across organs and is a major cause of cancer mortality. Analysis of tumor sequencing data provides a means toward the reconstruction of routes of metastatic cell migrations. Our reconstructions demonstrated that many metastases were likely seeded from pre-existing metastasis of primary tumors. Additionally, multiple clone exchanges between tumor sites were common. In conclusion, the pattern of cancer cell migrations is often complex and is highly variable among patients. Dispersal routes of metastatic cells are not medically detected or even visible. A molecular evolutionary analysis of tumor variation provides a way to retrospectively infer metastatic migration histories and answer questions such as whether the majority of metastases are seeded from clones within primary tumors or seeded from clones within pre-existing metastases, as well as whether the evolution of metastases is generally consistent with any proposed models. We seek answers to these fundamental questions through a systematic patient-centric retrospective analysis that maps the dynamic evolutionary history of tumor cell migrations in many cancers. We analyzed tumor genetic heterogeneity in 51 cancer patients and found that most metastatic migration histories were best described by a hybrid of models of metastatic tumor evolution. Synthesizing across metastatic migration histories, we found new tumor seedings arising from clones of pre-existing metastases as often as they arose from clones from primary tumors. There were also many clone exchanges between the source and recipient tumors. Therefore, a molecular phylogenetic analysis of tumor variation provides a retrospective glimpse into general patterns of metastatic migration histories in cancer patients.
引用
收藏
页数:13
相关论文
共 48 条
  • [31] Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression
    Xie, Tao
    Musteanu, Monica
    Lopez-Casas, Pedro P.
    Shields, David J.
    Olson, Peter
    Rejto, Paul A.
    Hidalgo, Manuel
    PLOS ONE, 2015, 10 (11):
  • [32] KLK4 Induces Anti-Tumor Effects in Human Xenograft Mouse Models of Orthotopic and Metastatic Prostate Cancer
    Tse, Brian W-C
    Kryza, Thomas
    Yeh, Mei-Chun
    Dong, Ying
    Sokolowski, Kamil A.
    Walpole, Carina
    Dreyer, Tobias
    Felber, Johanna
    Harris, Jonathan
    Magdolen, Viktor
    Russell, Pamela J.
    Clements, Judith A.
    CANCERS, 2020, 12 (12) : 1 - 15
  • [33] Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models
    Luo, Ke-Wang
    Ko, Chun-Hay
    Yue, Grace G. L.
    Lee, Michelle Y. Y.
    Siu, Wing-Sum
    Lee, Julia K. M.
    Shum, Wai-Ting
    Fung, Kwok-Pui
    Leung, Ping-Chung
    Li, Gang
    Evdokiou, Andreas
    Lau, Clara B. S.
    CANCER LETTERS, 2013, 339 (01) : 42 - 48
  • [34] Transcriptomic Profiling of Tumor-Infiltrating CD4+TIM-3+ T Cells Reveals Their Suppressive, Exhausted, and Metastatic Characteristics in Colorectal Cancer Patients
    Nair, Varun Sasidharan
    Toor, Salman M.
    Taha, Rowaida Z.
    Ahmed, Ayman A.
    Kurer, Mohamed A.
    Murshed, Khaled
    Soofi, Madiha E.
    Ouararhni, Khalid
    Alajez, Nehad M.
    Abu Nada, Mohamed
    Elkord, Eyad
    VACCINES, 2020, 8 (01)
  • [35] Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1
    Godec, Abigail
    Jayasinghe, Reyka
    Chrisinger, John S. A.
    Prudner, Bethany
    Ball, Tyler
    Wang, Yuxi
    Srihari, Divya
    Kaushal, Madhurima
    Dietz, Hilary
    Zhang, Xiaochun
    Pekmezci, Melike
    Dahiya, Sonika
    Tao, Yu
    Luo, Jinqin
    Van Tine, Brian A.
    Ding, Li
    Gutmann, David H.
    Hirbe, Angela C.
    NEURO-ONCOLOGY ADVANCES, 2020, 2 : i75 - i84
  • [36] RNA sequencing reveals the differential expression profiles of RNA in metastatic triple negative breast cancer and identifies SHISA3 as an efficient tumor suppressor gene
    Khaled, Noura
    Sonnier, Nicolas
    Molnar, Ioana
    Ponelle-Chachuat, Flora
    Kossai, Myriam
    Radosevic-Robin, Nina
    Privat, Maud
    Bidet, Yannick
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (09): : 4568 - 4581
  • [37] Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients
    Zhang, Xi
    Hofmann, Simone
    Rack, Brigitte
    Harbeck, Nadia
    Jeschke, Udo
    Sixou, Sophie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (06)
  • [38] Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivo
    Blomberg, Evelina
    Silginer, Manuela
    Roth, Patrick
    Weller, Michael
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [39] Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response
    Sato, Yosuke
    Fu, Yu
    Liu, Hong
    Lee, Min Young
    Shaw, Michael H.
    BMC CANCER, 2021, 21 (01)
  • [40] Printing the Pathway Forward in Bone Metastatic Cancer Research: Applications of 3D Engineered Models and Bioprinted Scaffolds to Recapitulate the Bone-Tumor Niche
    Hughes, Anne M.
    Kolb, Alexus D.
    Shupp, Alison B.
    Shine, Kristy M.
    Bussard, Karen M.
    CANCERS, 2021, 13 (03) : 1 - 28